MY181007A - Scale drop disease (sdd) causative virus and derivatives thereof - Google Patents
Scale drop disease (sdd) causative virus and derivatives thereofInfo
- Publication number
- MY181007A MY181007A MYPI2015002848A MYPI2015002848A MY181007A MY 181007 A MY181007 A MY 181007A MY PI2015002848 A MYPI2015002848 A MY PI2015002848A MY PI2015002848 A MYPI2015002848 A MY PI2015002848A MY 181007 A MY181007 A MY 181007A
- Authority
- MY
- Malaysia
- Prior art keywords
- virus
- sdd
- derivatives
- scale drop
- causative virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00061—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00061—Methods of inactivation or attenuation
- C12N2710/00063—Methods of inactivation or attenuation by chemical treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to an isolated virus causing Scale Drop Disease in fish, to cell cultures comprising said virus, to vaccines on the basis of said virus and methods for the preparation of such a vaccine, to antibodies reactive with said virus, to diagnostic test kits for the detection of that virus and to uses of said virus.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13170063 | 2013-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY181007A true MY181007A (en) | 2020-12-15 |
Family
ID=48536728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2015002848A MY181007A (en) | 2013-05-31 | 2014-05-28 | Scale drop disease (sdd) causative virus and derivatives thereof |
Country Status (5)
Country | Link |
---|---|
CN (2) | CN110438090B (en) |
AU (1) | AU2014273183B2 (en) |
MY (1) | MY181007A (en) |
SG (1) | SG11201509830UA (en) |
WO (1) | WO2014191445A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI765902B (en) * | 2016-08-11 | 2022-06-01 | 荷蘭商英特威國際公司 | Novel fish pathogenic virus |
CN108315487B (en) * | 2018-04-16 | 2021-06-22 | 福建省农业科学院生物技术研究所 | Primer group and kit for detecting eel herpesvirus and application of primer group and kit |
CN111621550B (en) * | 2020-06-18 | 2021-08-10 | 中国水产科学研究院黄海水产研究所 | RPA reaction system suitable for rapid detection of mermaid subspecies of mermaid photobacterium |
CN114106112B (en) * | 2021-11-30 | 2023-07-07 | 西北农林科技大学 | Truncated expressed Mandarin infectious spleen and kidney necrosis virus main capsid protein and application thereof |
CN116121197B (en) * | 2022-09-28 | 2023-10-20 | 华南农业大学 | Monoclonal antibody of anti-iridovirus SDDV isolate of yellow-fin sea bream and application thereof |
CN116004483B (en) * | 2023-03-09 | 2023-06-02 | 四川厌氧生物科技有限责任公司 | Lactococcus garvieae for preventing or treating diarrhea and application thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0195792A (en) * | 1987-10-07 | 1989-04-13 | Sapporo Breweries Ltd | Novel substance 46nw-04a, production thereof and antiviral pharmaceutical containing said substance as active ingredient |
EP0382271B1 (en) | 1989-02-04 | 1994-12-21 | Akzo Nobel N.V. | Tocols as adjuvant in vaccine |
ID22487A (en) * | 1997-03-21 | 1999-10-21 | Yakult Honsha Cs Kk | PROFILACTIC AND THERAPEUTIC SUBSTANCE FOR INFECTION DISEASE FROM FISH AND FRAMES |
PT1140152E (en) | 1998-12-21 | 2003-11-28 | Akzo Nobel Nv | METHOD FOR PRODUCING INACTIVATED VACCINES ADJUVED WITH A / O EMULATION |
JP3780256B2 (en) * | 2000-09-15 | 2006-05-31 | アクゾ・ノベル・エヌ・ベー | Antigenic protein of white spot syndrome virus and use thereof |
CN101883580B (en) * | 2007-12-04 | 2013-12-25 | 施怀哲维克有限公司 | Subunit vaccine for aquaculture |
CN101507774B (en) * | 2009-03-20 | 2010-12-01 | 宫玉泰 | Traditional Chinese medicine for treating ichthyosis |
WO2012130723A1 (en) * | 2011-03-25 | 2012-10-04 | Intervet International B.V. | Salmonid alphavirus vaccine |
-
2014
- 2014-05-28 CN CN201910622924.8A patent/CN110438090B/en active Active
- 2014-05-28 AU AU2014273183A patent/AU2014273183B2/en active Active
- 2014-05-28 SG SG11201509830UA patent/SG11201509830UA/en unknown
- 2014-05-28 WO PCT/EP2014/061014 patent/WO2014191445A1/en active Application Filing
- 2014-05-28 CN CN201480031056.1A patent/CN105247043A/en active Pending
- 2014-05-28 MY MYPI2015002848A patent/MY181007A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2014273183A1 (en) | 2015-11-19 |
CN105247043A (en) | 2016-01-13 |
CN110438090B (en) | 2023-12-05 |
WO2014191445A1 (en) | 2014-12-04 |
SG11201509830UA (en) | 2015-12-30 |
AU2014273183B2 (en) | 2017-01-19 |
CN110438090A (en) | 2019-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY181007A (en) | Scale drop disease (sdd) causative virus and derivatives thereof | |
CL2018001051A1 (en) | Nucleic acid vaccines against varicella zoster virus (vzv) | |
MX2021000435A (en) | Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor. | |
CL2016002455A1 (en) | Multispecific antibodies. | |
BR112017001579A2 (en) | anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable cd3 antibodies and methods of use | |
CL2016001102A1 (en) | Novel anti-claudin antibodies and methods of use. | |
MX366275B (en) | Methods for detecting and measuring aggregation. | |
CL2015001266A1 (en) | Antihemagglutinin antibodies and methods of use. | |
MX350274B (en) | Vaccines for hsv-2. | |
BR112017009764A2 (en) | bispecific antibodies and methods of use in ophthalmology | |
BR112016013562A2 (en) | HUMANIZED ANTI-TAU(PS422) ANTIBODIES, THEIR USES, AND PHARMACEUTICAL FORMULATIONS | |
AR091582A1 (en) | VACCINES ATTENDED AGAINST STREPTOCOCCUS SUIS AND METHODS OF ELABORATION AND USE OF THE SAME | |
EA201891124A2 (en) | NEW FLOURED ADJUVANTS AND DELIVERY SYSTEMS | |
MX2017008096A (en) | Pestivirus. | |
CL2012003458A1 (en) | Vector comprising a campylobacter antigenic polypeptide; pharmaceutical composition comprising said vector; use of the vector to improve the subject's immune response to the antigenic polypeptide. | |
BR112015003032A8 (en) | isolated antibodies, isolated nucleic acids, host cell, method of producing an antibody, immunoconjugate, pharmaceutical formulation, use of the antibody and method of treatment of an individual. | |
EP3212672A4 (en) | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development | |
EP3491386A4 (en) | Immunoassay methods and compositions for detecting infection involving use of test antigens as cross-reactive control antigens | |
MX2016013584A (en) | Porcine parvovirus. | |
MX2014015766A (en) | Toll-like receptors and immunostimulatory oligonucleotides. | |
AR094810A1 (en) | PARVOVIRUS PORCINO 5B, METHODS OF USE AND VACCINE | |
EA201691091A1 (en) | DIAGNOSTIC REAGENTS FOR IMPROVED IN VIVO OR IN VITRO CELL-MEDIATED IMMUNOLOGICAL DIAGNOSTICS OF TUBERCULOSIS | |
ES2503516R1 (en) | IMMUNOGENIC COMPLEX FOR VACCINATION AND METHOD OF OBTAINING | |
WO2015061610A3 (en) | Human t cell line assay for evaluating the immunologic identity of glatiramer acetate preparations | |
WO2012114312A3 (en) | Exogenous internal positive control |